1-6 of 6
Robert W. Robey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors

Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet, William J.E. Frye, José M. González Dalmasy, Li Wang, Drake A. Russell, Lyn M. Huff, Andrew J. Perciaccante, Fatima Ali-Rahmani, Crystal C. Lipsey, Heidi M. Wade, Allison V. Mitchell, Siddhardha S. Maligireddy, David Terrero, Donna Butcher, Elijah F. Edmondson, Lisa M. Jenkins, Tatiana Nikitina, Victor B. Zhurkin, Amit K. Tiwari, Anthony D. Piscopio, Rheem A. Totah, Susan E. Bates, H. Efsun Arda, Michael M. Gottesman, Pedro J. Batista
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (4): 464–477.
https://doi.org/10.1158/1535-7163.MCT-23-0144
Published: 02 April 2024
View article titled, The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
Open the PDF for The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors in another window
Includes: Supplementary data
Journal Articles

Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

Joshua T. Kowalczyk, Xiaolin Wan, Edjay R. Hernandez, Ruibai Luo, Gaelyn C. Lyons, Kelli M. Wilson, Devorah C. Gallardo, Kristine A. Isanogle, Christina M. Robinson, Arnulfo Mendoza, Christine M. Heske, Jinqui-Qiu Chen, Xiaoling Luo, Alexander E. Kelly, Simone Difilippantinio, Robert W. Robey, Craig J. Thomas, Dan L. Sackett, Deborah K. Morrison, Paul A. Randazzo, Lisa M. Miller Jenkins, Marielle E. Yohe
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (2): 307–319.
https://doi.org/10.1158/1535-7163.MCT-20-0525
Published: 05 February 2021
View article titled, Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma
Open the PDF for Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2

Kenneth K.W. To, Robert W. Robey, Turid Knutsen, Zhirong Zhan, Thomas Ried, Susan E. Bates
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2959–2968.
https://doi.org/10.1158/1535-7163.MCT-09-0292
Published: 12 October 2009
View article titled, Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
Open the PDF for Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2 in another window
Includes: Supplementary data
Journal Articles

New inhibitors of ABCG2 identified by high-throughput screening

Curtis J. Henrich, Robert W. Robey, Heidi R. Bokesch, Susan E. Bates, Suneet Shukla, Suresh V. Ambudkar, Michael Dean, James B. McMahon
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (12): 3271–3278.
https://doi.org/10.1158/1535-7163.MCT-07-0352
Published: 18 December 2007
View article titled, New inhibitors of ABCG2 identified by high-throughput screening
Open the PDF for New inhibitors of ABCG2 identified by high-throughput screening in another window
Journal Articles

Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure

Robert W. Robey, Suneet Shukla, Kenneth Steadman, Tomasz Obrzut, Elizabeth M. Finley, Suresh V. Ambudkar, Susan E. Bates
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (6): 1877–1885.
https://doi.org/10.1158/1535-7163.MCT-06-0811
Published: 15 June 2007
View article titled, Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure
Open the PDF for Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure in another window
Journal Articles

A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities

Pui-Kai Li, Bulbul Pandit, Dan L. Sackett, Zhigen Hu, Jennifer Zink, Jiandong Zhi, Dena Freeman, Robert W. Robey, Karl Werbovetz, Andrew Lewis, Chenglong Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (2): 450–456.
https://doi.org/10.1158/1535-7163.MCT-05-0254
Published: 27 February 2006
View article titled, A thalidomide analogue with <em>in vitro</em> antiproliferative, antimitotic, and microtubule-stabilizing activities
Open the PDF for A thalidomide analogue with <em>in vitro</em> antiproliferative, antimitotic, and microtubule-stabilizing activities in another window